secwatch.observer — SEC 8-K summary
======================================

Issuer:     Entera Bio Ltd. (ENTXW)
CIK:        0001638097
Form:       8-K
Filed at:   2023-06-30T23:59:59+00:00
Accession:  0001178913-23-002344
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Entera Bio receives Nasdaq minimum bid price deficiency notice; faces potential delisting
--------------------------------------------------------------------------------

- Received Nasdaq notice for failing $1.00 minimum bid price for 30 consecutive business days.
- Initial 180-day compliance period ends December 26, 2023; must close at $1.00 for 10 consecutive days.
- If not cured, may qualify for additional 180-day period with conditions including reverse stock split.
- Company states the notice has no effect on its business operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638097/000117891323002344/0001178913-23-002344-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638097/000117891323002344/zk2329931.htm
  HTML page:      https://secwatch.observer/filing/0001178913-23-002344

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer